Declining in-hospital mortality in vasculitis: A 17-year US national study

Kaynakça (1)

1. Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA. Mortality in ANCA-associated vasculitis: A meta-analysis of observational studies. Ann Rheum Dis. 2017;76:1566-74. [Crossref] 2. Steinberg AW, Wechsler ME, Fernandez PE. Trends in antineutrophil cytoplasmic autoantibody- associated vasculitis-related mortality in the United States, 1999 to 2017. Ann Intern Med. 2020;172:160-3. [Crossref] 3. Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70:488-94. [Crossref] 4. Bernatsky S, Linehan T, Hanly JG. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol. 2011;38:1612-6. [Crossref] 5. Smith RM. Update on the treatment of ANCA associated vasculitis. Presse Med. 2015;44: E241-9. [Crossref] 6. Zerizer I, Tan K, Khan S, et al. Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol. 2010;73:504-9. [Crossref] 7. Raman SV, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Magn Reson. 2012;14:82. [Crossref] 8. Moosig F, Bremer JP, Hellmich B, et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg- Strauss, EGPA): Monocentric experiences in 150 patients. Ann Rheum Dis. 2013;72:1011-7. [Crossref] 9. Eriksson P, Jacobsson L, Lindell A, Nilsson JA, Skogh T. Improved outcome in Wegener’s granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts. J Intern Med. 2009;265:496-506. [Crossref] 10. Holle JU, Gross WL, Latza U, et al. Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum. 2011;63:257-66. [Crossref]